SCNX
Scienture Holdings, Inc.NASDAQHEALTHCAREPHARMACEUTICAL RETAILERS
Key Statistics
Market Cap
$15.89M
P/E Ratio
—
EPS
$-2.63
Beta
—
52W High
$2.60
52W Low
$0.24
50-Day MA
$0.40
200-Day MA
$0.76
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
21.51
PEG Ratio
—
About Scienture Holdings, Inc.
Scienture Holdings, Inc. (SCNX) is a biotechnology company dedicated to advancing therapeutic solutions for neurological disorders through its innovative drug development pipeline. Leveraging cutting-edge technology and a highly proficient research team, Scienture aims to address significant unmet medical needs while enhancing patient outcomes. The company's unwavering commitment to scientific excellence, regulatory adherence, and strategic partnerships not only fuels its growth prospects but also underscores its potential to deliver impactful contributions to global healthcare advancements. As the healthcare sector continues to expand, SCNX is well-positioned to capitalize on emerging opportunities in the neurological treatment landscape.
Fundamentals
| Revenue (TTM) | 431,610 |
| Gross Profit (TTM) | 331,480 |
| EBITDA | $-15.79M |
| Operating Margin | 1870.00% |
| Return on Equity | -55.60% |
| Return on Assets | -10.70% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $1.73 |
| Price-to-Book | 0.23 |
| Price-to-Sales (TTM) | 36.81 |
| EV/Revenue | 22.39 |
| EV/EBITDA | -1.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 810.00% |
| Shares Outstanding | $40.63M |
| Float | $32.79M |
| % Insiders | 21.88% |
| % Institutions | 3.72% |
More HEALTHCARE Stocks
Data last updated: 5/5/2026